<DOC>
	<DOCNO>NCT00614029</DOCNO>
	<brief_summary>A study evaluate pharmacokinetics bioequivalence sumatriptan deliver Intraject system .</brief_summary>
	<brief_title>A Study Evaluate Pharmacokinetics Bioequivalence Sumatriptan Delivered Via Intraject System</brief_title>
	<detailed_description>A single center , randomize , single-dose , open-label , partial-block , four-period , four-way crossover study 54 healthy adult subject evaluate pharmacokinetics bioequivalence sumatriptan deliver Intraject system compare IMITREX STATdose three injection site ( abdomen , thigh , arm . )</detailed_description>
	<mesh_term>Sumatriptan</mesh_term>
	<criteria>Healthy subject Negative serum pregnancy test Female subject childbearing potential must agree use acceptable birth control 3 week prior 2 week study dose . Body Mass Index ( BMI ) sufficient subcutaneous thickness , opinion investigator , injection abdomen , arm thigh Nontobacco user Adequate venous access leave right arm allow collection number blood sample Fluent English language Provide write informed consent participate study willing comply study procedure History within previous 2 year drug alcohol dependence Evidence clinically relevant oral , cardiovascular , hematologic , gastrointestinal , hepatic , renal , endocrine , pulmonary , neurologic , psychiatric skin disorder History epilepsy neurologic disease History coronary disease , peripheral vascular disease , cerebrovascular accident , transient ischemic attack , uncontrolled hypertension , signs/symptoms ischemic heart disease History allergy , anaphylaxis , hypersensitivity sumatriptan similar drug include sulphonamides History scleroderma skin condition may adversely affect injection absorption subcutaneously administer medication Tattoos birthmarks lateral thigh , abdominal area arm ( deltoid ) large enough restrict injection site selection and/or evaluation Positive screen test HIV antibody , Hepatitis B surface antigen , Hepatitis C antibody Positive result illicit drug test Screening Checkin Use prescription medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>sumatriptan</keyword>
	<keyword>Injections</keyword>
	<keyword>Subcutaneous</keyword>
</DOC>